# pathway_0147: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0147.txt)

**Task:** `pathway`  
**Author key, unchanged:** **A** — Secondary metabolite biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSANTGKPARHYLISYPRTASNLLLKILALDSQPNFSSGGFDGGYFFMPADDILTDPRIRVRARSISDWTADERAQLKETFQACFEAQQRWLESAESQGQSVFVKEHTVFFADPTARSCLQFGPSATSEPAWTVEYAGGSTHSKLNITVLPDEFLLTWLPTFLIRHPALAFPSLYRTVIKREGKESAAADNFASLLTTVEWSRSLYDFYVQNRESLPCSPDQRLEWPIVLDADDIIAHPATVTLYCDKIGMDPRQLCFNWDQLKSEELSKIEPNQLAMRMSLYQSTGIDTSKSSRGINVDDEATKWRSEFGIAVADHIEKLVRGAMADYEYLRARRLRAD

[Multiple Choices]
A. Secondary metabolite biosynthesis. .
B. Alkaloid biosynthesis
C. pyruvate from D-glyceraldehyde 3-phosphate: step 2/5. .
D. ergot alkaloid biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry A0A455ZLR3, which annotates this protein's pathway as “Secondary metabolite biosynthesis,” consistent with choice A. The annotation is linked to a cited publication, but the supplied excerpts do not establish a direct experimental measurement of pathway function.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a sufficiently specific argument to identify this protein's pathway among the listed choices; recognizing a general enzyme family would not resolve its particular biosynthetic-cluster role.


**Missing item-specific fact**

> The protein-specific annotation that this sequence is sulfotransferase ppzF in a pyrrolopyrazine biosynthesis cluster, with a secondary-metabolite-biosynthesis pathway assignment.


**Reason**

> The pathway assignment depends on the protein's specific cluster annotation and associated literature, neither of which is supplied in the question. Exact-sequence recognition or recall of its database entry would be lookup or memorization, not reasoning from the provided input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Secondary metabolite biosynthesis is a broad category that can include alkaloid biosynthesis, so A and B are not necessarily mutually exclusive. The matched database annotation supports A, but the option wording does not explicitly distinguish a broad pathway category from a more specific product-class category.


### Important caveats

- Reviewer-only database evidence supports the expected answer but was absent from the evaluated model input.
- The cited UniProt pathway annotation is linked to literature; these excerpts alone do not establish direct experimental validation.
- The author’s exact source snapshot is unknown, although a historical UniProt record with the matching sequence also contains the same pathway annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific argument to identify this protein's pathway among the listed choices; recognizing a general enzyme family would not resolve its particular biosynthetic-cluster role.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation that this sequence is sulfotransferase ppzF in a pyrrolopyrazine biosynthesis cluster, with a secondary-metabolite-biosynthesis pathway assignment.",
    "reason": "The pathway assignment depends on the protein's specific cluster annotation and associated literature, neither of which is supplied in the question. Exact-sequence recognition or recall of its database entry would be lookup or memorization, not reasoning from the provided input."
  },
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A455ZLR3, which annotates this protein's pathway as “Secondary metabolite biosynthesis,” consistent with choice A. The annotation is linked to a cited publication, but the supplied excerpts do not establish a direct experimental measurement of pathway function."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the expected answer but was absent from the evaluated model input.",
    "The cited UniProt pathway annotation is linked to literature; these excerpts alone do not establish direct experimental validation.",
    "The author’s exact source snapshot is unknown, although a historical UniProt record with the matching sequence also contains the same pathway annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Secondary metabolite biosynthesis is a broad category that can include alkaloid biosynthesis, so A and B are not necessarily mutually exclusive. The matched database annotation supports A, but the option wording does not explicitly distinguish a broad pathway category from a more specific product-class category."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A455ZLR3, which annotates this protein's pathway as “Secondary metabolite biosynthesis,” consistent with choice A. The annotation is linked to a cited publication, but the supplied excerpts do not establish a direct experimental measurement of pathway function.",
    "evidence_ids": ["C1", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific argument to identify this protein's pathway among the listed choices; recognizing a general enzyme family would not resolve its particular biosynthetic-cluster role.",
    "missing_item_specific_fact": "The protein-specific annotation that this sequence is sulfotransferase ppzF in a pyrrolopyrazine biosynthesis cluster, with a secondary-metabolite-biosynthesis pathway assignment.",
    "reason": "The pathway assignment depends on the protein's specific cluster annotation and associated literature, neither of which is supplied in the question. Exact-sequence recognition or recall of its database entry would be lookup or memorization, not reasoning from the provided input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Secondary metabolite biosynthesis is a broad category that can include alkaloid biosynthesis, so A and B are not necessarily mutually exclusive. The matched database annotation supports A, but the option wording does not explicitly distinguish a broad pathway category from a more specific product-class category."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the expected answer but was absent from the evaluated model input.",
    "The cited UniProt pathway annotation is linked to literature; these excerpts alone do not establish direct experimental validation.",
    "The author’s exact source snapshot is unknown, although a historical UniProt record with the matching sequence also contains the same pathway annotation."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A455ZLR3 (Sulfotransferase ppzF / Pyrrolopyrazine biosynthesis cluster protein F from Metarhizium majus ARSEF 297) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305, PubMed:30452111). The protein is a sulfotransferase (EC 2.8.2.-) in the pyrrolopyrazine biosynthetic gene cluster, which UniProt classifies under the broad 'Secondary metabolite biosynthesis' pathway. The sequence in the question matches the UniProt entry exactly (340 aa, SHA-256 confirmed).

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could eliminate choice C (glycolytic step) by recognizing the sulfotransferase fold and transferase function, inconsistent with glycolysis. However, distinguishing A ('Secondary metabolite biosynthesis') from B ('Alkaloid biosynthesis') requires knowing that UniProt's pathway taxonomy classifies pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under 'Alkaloid biosynthesis,' even though pyrrolopyrazines are nitrogen-containing heterocyclic natural products that satisfy a chemical definition of 'alkaloid.' Distinguishing A from D requires knowing that pyrrolopyrazine biosynthesis is a distinct pathway from ergot alkaloid biosynthesis despite sharing tryptophan-derived precursors.


**Missing item-specific fact**

> The specific UniProt pathway taxonomy assignment for pyrrolopyrazine biosynthesis (i.e., that it is annotated under 'Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis' or 'Ergot alkaloid biosynthesis'). This is a database classification decision not derivable from the sequence alone.


**Reason**

> While the sulfotransferase domain and fungal origin narrow the field, the critical distinction between the broad 'Secondary metabolite biosynthesis' label and the more specific 'Alkaloid biosynthesis' label depends on UniProt's particular pathway hierarchy for pyrrolopyrazine biosynthesis. A chemically literate model might reasonably classify pyrrolopyrazines as alkaloids. The correct answer depends on knowing the specific annotation taxonomy rather than on general biochemical reasoning from the sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Pyrrolopyrazines are nitrogen-containing heterocyclic compounds produced by fungi, which satisfies the general chemical definition of an alkaloid. A model reasoning from first principles could defensibly select B ('Alkaloid biosynthesis') as the pathway. The choice of A over B rests on UniProt's specific pathway taxonomy, which places pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under an 'alkaloid' sub-pathway. Choice D is less defensible since pyrrolopyrazines are biosynthetically and structurally distinct from ergot alkaloids (e.g., ergotamine, ergometrine).


### Important caveats

- The UniProt pathway annotation carries evidence code ECO:0000305 (inferred from a single PubMed reference, 30452111), indicating it was derived from the biosynthetic gene cluster characterization paper rather than direct enzymatic assay of this specific step.
- The 'Secondary metabolite biosynthesis' pathway label in UniProt is a broad umbrella category; it is not a specific metabolic pathway in the KEGG/Reactome sense but a UniProt-internal classification.
- The identity of the protein as ppzF was inferred from dataset metadata (reviewer-only); the evaluated model received only the raw sequence with no accession or organism information.
- Choice C (pyruvate from D-glyceraldehyde 3-phosphate: step 2/5) is an obvious glycolysis distractor irrelevant to a sulfotransferase.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could eliminate choice C (glycolytic step) by recognizing the sulfotransferase fold and transferase function, inconsistent with glycolysis. However, distinguishing A ('Secondary metabolite biosynthesis') from B ('Alkaloid biosynthesis') requires knowing that UniProt's pathway taxonomy classifies pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under 'Alkaloid biosynthesis,' even though pyrrolopyrazines are nitrogen-containing heterocyclic natural products that satisfy a chemical definition of 'alkaloid.' Distinguishing A from D requires knowing that pyrrolopyrazine biosynthesis is a distinct pathway from ergot alkaloid biosynthesis despite sharing tryptophan-derived precursors.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific UniProt pathway taxonomy assignment for pyrrolopyrazine biosynthesis (i.e., that it is annotated under 'Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis' or 'Ergot alkaloid biosynthesis'). This is a database classification decision not derivable from the sequence alone.",
    "reason": "While the sulfotransferase domain and fungal origin narrow the field, the critical distinction between the broad 'Secondary metabolite biosynthesis' label and the more specific 'Alkaloid biosynthesis' label depends on UniProt's particular pathway hierarchy for pyrrolopyrazine biosynthesis. A chemically literate model might reasonably classify pyrrolopyrazines as alkaloids. The correct answer depends on knowing the specific annotation taxonomy rather than on general biochemical reasoning from the sequence."
  },
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZLR3 (Sulfotransferase ppzF / Pyrrolopyrazine biosynthesis cluster protein F from Metarhizium majus ARSEF 297) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305, PubMed:30452111). The protein is a sulfotransferase (EC 2.8.2.-) in the pyrrolopyrazine biosynthetic gene cluster, which UniProt classifies under the broad 'Secondary metabolite biosynthesis' pathway. The sequence in the question matches the UniProt entry exactly (340 aa, SHA-256 confirmed)."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000305 (inferred from a single PubMed reference, 30452111), indicating it was derived from the biosynthetic gene cluster characterization paper rather than direct enzymatic assay of this specific step.",
    "The 'Secondary metabolite biosynthesis' pathway label in UniProt is a broad umbrella category; it is not a specific metabolic pathway in the KEGG/Reactome sense but a UniProt-internal classification.",
    "The identity of the protein as ppzF was inferred from dataset metadata (reviewer-only); the evaluated model received only the raw sequence with no accession or organism information.",
    "Choice C (pyruvate from D-glyceraldehyde 3-phosphate: step 2/5) is an obvious glycolysis distractor irrelevant to a sulfotransferase."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Pyrrolopyrazines are nitrogen-containing heterocyclic compounds produced by fungi, which satisfies the general chemical definition of an alkaloid. A model reasoning from first principles could defensibly select B ('Alkaloid biosynthesis') as the pathway. The choice of A over B rests on UniProt's specific pathway taxonomy, which places pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under an 'alkaloid' sub-pathway. Choice D is less defensible since pyrrolopyrazines are biosynthetically and structurally distinct from ergot alkaloids (e.g., ergotamine, ergometrine)."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZLR3 (Sulfotransferase ppzF / Pyrrolopyrazine biosynthesis cluster protein F from Metarhizium majus ARSEF 297) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305, PubMed:30452111). The protein is a sulfotransferase (EC 2.8.2.-) in the pyrrolopyrazine biosynthetic gene cluster, which UniProt classifies under the broad 'Secondary metabolite biosynthesis' pathway. The sequence in the question matches the UniProt entry exactly (340 aa, SHA-256 confirmed).",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could eliminate choice C (glycolytic step) by recognizing the sulfotransferase fold and transferase function, inconsistent with glycolysis. However, distinguishing A ('Secondary metabolite biosynthesis') from B ('Alkaloid biosynthesis') requires knowing that UniProt's pathway taxonomy classifies pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under 'Alkaloid biosynthesis,' even though pyrrolopyrazines are nitrogen-containing heterocyclic natural products that satisfy a chemical definition of 'alkaloid.' Distinguishing A from D requires knowing that pyrrolopyrazine biosynthesis is a distinct pathway from ergot alkaloid biosynthesis despite sharing tryptophan-derived precursors.",
    "missing_item_specific_fact": "The specific UniProt pathway taxonomy assignment for pyrrolopyrazine biosynthesis (i.e., that it is annotated under 'Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis' or 'Ergot alkaloid biosynthesis'). This is a database classification decision not derivable from the sequence alone.",
    "reason": "While the sulfotransferase domain and fungal origin narrow the field, the critical distinction between the broad 'Secondary metabolite biosynthesis' label and the more specific 'Alkaloid biosynthesis' label depends on UniProt's particular pathway hierarchy for pyrrolopyrazine biosynthesis. A chemically literate model might reasonably classify pyrrolopyrazines as alkaloids. The correct answer depends on knowing the specific annotation taxonomy rather than on general biochemical reasoning from the sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Pyrrolopyrazines are nitrogen-containing heterocyclic compounds produced by fungi, which satisfies the general chemical definition of an alkaloid. A model reasoning from first principles could defensibly select B ('Alkaloid biosynthesis') as the pathway. The choice of A over B rests on UniProt's specific pathway taxonomy, which places pyrrolopyrazine biosynthesis under the broad 'Secondary metabolite biosynthesis' heading rather than under an 'alkaloid' sub-pathway. Choice D is less defensible since pyrrolopyrazines are biosynthetically and structurally distinct from ergot alkaloids (e.g., ergotamine, ergometrine)."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000305 (inferred from a single PubMed reference, 30452111), indicating it was derived from the biosynthetic gene cluster characterization paper rather than direct enzymatic assay of this specific step.",
    "The 'Secondary metabolite biosynthesis' pathway label in UniProt is a broad umbrella category; it is not a specific metabolic pathway in the KEGG/Reactome sense but a UniProt-internal classification.",
    "The identity of the protein as ppzF was inferred from dataset metadata (reviewer-only); the evaluated model received only the raw sequence with no accession or organism information.",
    "Choice C (pyruvate from D-glyceraldehyde 3-phosphate: step 2/5) is an obvious glycolysis distractor irrelevant to a sulfotransferase."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record explicitly assigns the pathway as “Secondary metabolite biosynthesis,” citing a paper that reports function and pathway. This supports A as an annotation, though the excerpts do not independently establish the experimental basis or strength of that assignment.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein’s specific association with the pyrrolopyrazine biosynthetic cluster and the pathway assignment for that cluster are not supplied by the sequence or choices.


**Reason**

> A sulfotransferase-like sequence could suggest modification of a metabolite, but that transferable clue does not meaningfully distinguish general secondary-metabolite biosynthesis from alkaloid biosynthesis, or identify an ergot-alkaloid pathway. Selecting the recorded pathway requires a target-specific pathway or cluster association.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Secondary-metabolite biosynthesis is a broad category that can include alkaloid biosynthesis. The choices do not say whether they are intended as mutually exclusive levels of pathway specificity; the supplied evidence supports A but does not resolve whether the more specific B label is also applicable.


### Important caveats

- The pathway excerpts are database annotations citing a paper; they are not themselves a direct experimental demonstration.
- The sequence-matched source identity and its annotations were reviewer-only, not original model inputs.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s specific association with the pyrrolopyrazine biosynthetic cluster and the pathway assignment for that cluster are not supplied by the sequence or choices.",
    "reason": "A sulfotransferase-like sequence could suggest modification of a metabolite, but that transferable clue does not meaningfully distinguish general secondary-metabolite biosynthesis from alkaloid biosynthesis, or identify an ergot-alkaloid pathway. Selecting the recorded pathway requires a target-specific pathway or cluster association."
  },
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record explicitly assigns the pathway as “Secondary metabolite biosynthesis,” citing a paper that reports function and pathway. This supports A as an annotation, though the excerpts do not independently establish the experimental basis or strength of that assignment."
  },
  "important_caveats": [
    "The pathway excerpts are database annotations citing a paper; they are not themselves a direct experimental demonstration.",
    "The sequence-matched source identity and its annotations were reviewer-only, not original model inputs."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Secondary-metabolite biosynthesis is a broad category that can include alkaloid biosynthesis. The choices do not say whether they are intended as mutually exclusive levels of pathway specificity; the supplied evidence supports A but does not resolve whether the more specific B label is also applicable."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record explicitly assigns the pathway as “Secondary metabolite biosynthesis,” citing a paper that reports function and pathway. This supports A as an annotation, though the excerpts do not independently establish the experimental basis or strength of that assignment.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein’s specific association with the pyrrolopyrazine biosynthetic cluster and the pathway assignment for that cluster are not supplied by the sequence or choices.",
    "reason": "A sulfotransferase-like sequence could suggest modification of a metabolite, but that transferable clue does not meaningfully distinguish general secondary-metabolite biosynthesis from alkaloid biosynthesis, or identify an ergot-alkaloid pathway. Selecting the recorded pathway requires a target-specific pathway or cluster association."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Secondary-metabolite biosynthesis is a broad category that can include alkaloid biosynthesis. The choices do not say whether they are intended as mutually exclusive levels of pathway specificity; the supplied evidence supports A but does not resolve whether the more specific B label is also applicable."
  },
  "important_caveats": [
    "The pathway excerpts are database annotations citing a paper; they are not themselves a direct experimental demonstration.",
    "The sequence-matched source identity and its annotations were reviewer-only, not original model inputs."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation for this sequence (A0A455ZLR3, Sulfotransferase ppzF from Metarhizium majus) explicitly states PATHWAY: Secondary metabolite biosynthesis, supported by evidence code ECO:0000305|PubMed:30452111. The protein is part of the pyrrolopyrazine biosynthesis gene cluster. The sequence matches the benchmark input exactly.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Options C and D can be partially eliminated by reasoning: C (pyruvate from G3P, glycolysis step) is incompatible with a fungal sulfotransferase, and D (ergot alkaloid biosynthesis) involves a very specific enzymatic cascade (LDMTS, C-8 prenyltransferase, etc.) in which sulfotransferases are not typical components. However, distinguishing A (Secondary metabolite biosynthesis) from B (Alkaloid biosynthesis) is not achievable by transferable knowledge: pyrrolopyrazine IS an alkaloid, so 'Alkaloid biosynthesis' is arguably equally or more accurate. The choice of 'Secondary metabolite biosynthesis' over 'Alkaloid biosynthesis' reflects UniProt's specific pathway-ontology annotation convention for this particular protein, not a biologically necessary distinction derivable from the sequence or general knowledge.


**Missing item-specific fact**

> The specific UniProt pathway-ontology term assigned to this protein ('Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis'), which is a database annotation choice for this exact protein and not derivable from sequence features or general pathway knowledge, since pyrrolopyrazine is both a secondary metabolite and an alkaloid.


**Reason**

> While C and D can be reasonably excluded by general biological reasoning (sulfotransferases are not glycolytic enzymes; ergot alkaloid biosynthesis has a distinct enzymatic architecture), the A-vs-B distinction requires knowing the specific database annotation for this protein. Pyrrolopyrazine is an alkaloid, making B a defensible alternative. No sequence feature or family-level inference reliably forces the broader 'Secondary metabolite biosynthesis' term over the more specific 'Alkaloid biosynthesis' term without recalling this protein's UniProt record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Pyrrolopyrazine is both a secondary metabolite and an alkaloid. Option A ('Secondary metabolite biosynthesis') is the UniProt annotation, but option B ('Alkaloid biosynthesis') is biologically accurate since pyrrolopyrazine is structurally and biosynthetically an alkaloid. Without access to the specific UniProt pathway-ontology assignment, a knowledgeable model could reasonably select either A or B.


### Important caveats

- The UniProt pathway annotation uses 'Secondary metabolite biosynthesis' as a controlled-vocabulary term; this is a broad parent category in UniProt's pathway ontology, and the choice not to assign a more specific 'Alkaloid biosynthesis' term is an annotation convention rather than a biological exclusion.
- The PubMed reference (30452111, 2019) characterizing the pyrrolopyrazine cluster is the primary evidence for the pathway assignment; the annotation is based on gene-cluster context and functional characterization, not solely on sequence features of ppzF.
- The protein's sulfotransferase activity (EC 2.8.2.-) is consistent with secondary metabolism but does not by itself specify which secondary metabolite pathway.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Options C and D can be partially eliminated by reasoning: C (pyruvate from G3P, glycolysis step) is incompatible with a fungal sulfotransferase, and D (ergot alkaloid biosynthesis) involves a very specific enzymatic cascade (LDMTS, C-8 prenyltransferase, etc.) in which sulfotransferases are not typical components. However, distinguishing A (Secondary metabolite biosynthesis) from B (Alkaloid biosynthesis) is not achievable by transferable knowledge: pyrrolopyrazine IS an alkaloid, so 'Alkaloid biosynthesis' is arguably equally or more accurate. The choice of 'Secondary metabolite biosynthesis' over 'Alkaloid biosynthesis' reflects UniProt's specific pathway-ontology annotation convention for this particular protein, not a biologically necessary distinction derivable from the sequence or general knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific UniProt pathway-ontology term assigned to this protein ('Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis'), which is a database annotation choice for this exact protein and not derivable from sequence features or general pathway knowledge, since pyrrolopyrazine is both a secondary metabolite and an alkaloid.",
    "reason": "While C and D can be reasonably excluded by general biological reasoning (sulfotransferases are not glycolytic enzymes; ergot alkaloid biosynthesis has a distinct enzymatic architecture), the A-vs-B distinction requires knowing the specific database annotation for this protein. Pyrrolopyrazine is an alkaloid, making B a defensible alternative. No sequence feature or family-level inference reliably forces the broader 'Secondary metabolite biosynthesis' term over the more specific 'Alkaloid biosynthesis' term without recalling this protein's UniProt record."
  },
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation for this sequence (A0A455ZLR3, Sulfotransferase ppzF from Metarhizium majus) explicitly states PATHWAY: Secondary metabolite biosynthesis, supported by evidence code ECO:0000305|PubMed:30452111. The protein is part of the pyrrolopyrazine biosynthesis gene cluster. The sequence matches the benchmark input exactly."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses 'Secondary metabolite biosynthesis' as a controlled-vocabulary term; this is a broad parent category in UniProt's pathway ontology, and the choice not to assign a more specific 'Alkaloid biosynthesis' term is an annotation convention rather than a biological exclusion.",
    "The PubMed reference (30452111, 2019) characterizing the pyrrolopyrazine cluster is the primary evidence for the pathway assignment; the annotation is based on gene-cluster context and functional characterization, not solely on sequence features of ppzF.",
    "The protein's sulfotransferase activity (EC 2.8.2.-) is consistent with secondary metabolism but does not by itself specify which secondary metabolite pathway."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Pyrrolopyrazine is both a secondary metabolite and an alkaloid. Option A ('Secondary metabolite biosynthesis') is the UniProt annotation, but option B ('Alkaloid biosynthesis') is biologically accurate since pyrrolopyrazine is structurally and biosynthetically an alkaloid. Without access to the specific UniProt pathway-ontology assignment, a knowledgeable model could reasonably select either A or B."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0147",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation for this sequence (A0A455ZLR3, Sulfotransferase ppzF from Metarhizium majus) explicitly states PATHWAY: Secondary metabolite biosynthesis, supported by evidence code ECO:0000305|PubMed:30452111. The protein is part of the pyrrolopyrazine biosynthesis gene cluster. The sequence matches the benchmark input exactly.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Options C and D can be partially eliminated by reasoning: C (pyruvate from G3P, glycolysis step) is incompatible with a fungal sulfotransferase, and D (ergot alkaloid biosynthesis) involves a very specific enzymatic cascade (LDMTS, C-8 prenyltransferase, etc.) in which sulfotransferases are not typical components. However, distinguishing A (Secondary metabolite biosynthesis) from B (Alkaloid biosynthesis) is not achievable by transferable knowledge: pyrrolopyrazine IS an alkaloid, so 'Alkaloid biosynthesis' is arguably equally or more accurate. The choice of 'Secondary metabolite biosynthesis' over 'Alkaloid biosynthesis' reflects UniProt's specific pathway-ontology annotation convention for this particular protein, not a biologically necessary distinction derivable from the sequence or general knowledge.",
    "missing_item_specific_fact": "The specific UniProt pathway-ontology term assigned to this protein ('Secondary metabolite biosynthesis' rather than 'Alkaloid biosynthesis'), which is a database annotation choice for this exact protein and not derivable from sequence features or general pathway knowledge, since pyrrolopyrazine is both a secondary metabolite and an alkaloid.",
    "reason": "While C and D can be reasonably excluded by general biological reasoning (sulfotransferases are not glycolytic enzymes; ergot alkaloid biosynthesis has a distinct enzymatic architecture), the A-vs-B distinction requires knowing the specific database annotation for this protein. Pyrrolopyrazine is an alkaloid, making B a defensible alternative. No sequence feature or family-level inference reliably forces the broader 'Secondary metabolite biosynthesis' term over the more specific 'Alkaloid biosynthesis' term without recalling this protein's UniProt record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Pyrrolopyrazine is both a secondary metabolite and an alkaloid. Option A ('Secondary metabolite biosynthesis') is the UniProt annotation, but option B ('Alkaloid biosynthesis') is biologically accurate since pyrrolopyrazine is structurally and biosynthetically an alkaloid. Without access to the specific UniProt pathway-ontology assignment, a knowledgeable model could reasonably select either A or B."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses 'Secondary metabolite biosynthesis' as a controlled-vocabulary term; this is a broad parent category in UniProt's pathway ontology, and the choice not to assign a more specific 'Alkaloid biosynthesis' term is an annotation convention rather than a biological exclusion.",
    "The PubMed reference (30452111, 2019) characterizing the pyrrolopyrazine cluster is the primary evidence for the pathway assignment; the annotation is based on gene-cluster context and functional characterization, not solely on sequence features of ppzF.",
    "The protein's sulfotransferase activity (EC 2.8.2.-) is consistent with secondary metabolism but does not by itself specify which secondary metabolite pathway."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A455ZLR3",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "e316590a6f1ebb768b4cd2ae53d0b5fb1deefd8c6c5ffb22c77db65f75c3048a",
  "benchmark_sequence_length": 340,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 11,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2019-06-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "current_source_sequence_sha256": "e316590a6f1ebb768b4cd2ae53d0b5fb1deefd8c6c5ffb22c77db65f75c3048a",
  "current_source_sequence_length": 340,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 10,
  "selected_historical_version": {
    "accession": "A0A455ZLR3",
    "database": "Swiss-Prot",
    "entryVersion": 10,
    "firstRelease": "2025_02/2025_02",
    "firstReleaseDate": "23-Apr-2025",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "PPZF_METMF",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "ddc350505f9daf759d0d04d56b92ba49afb5a19348f35aee2a744b896e240a4d",
  "selected_historical_source_sequence_sha256": "e316590a6f1ebb768b4cd2ae53d0b5fb1deefd8c6c5ffb22c77db65f75c3048a",
  "selected_historical_source_sequence_length": 340,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 10,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A455ZLR3\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":11,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2019-06-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Clavicipitaceae\",\"Metarhizium\",\"Metarhizium majus\"],\"scientificName\":\"Metarhizium majus (strain ARSEF 297)\",\"taxonId\":1276143}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Pyrrolopyrazine biosynthesis cluster protein F\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"2.8.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Sulfotransferase ppzF\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZLR3.json",
  "source_sha256": "4f03679da2666fc918baa51a3273afd0d45dc9c660388a0fe8eed237cb3a398d",
  "retrieved_utc": "2026-11-02T04:25:16.946847+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Berry D.\",\"Mace W.\",\"Rehner S.A.\",\"Grage K.\",\"Dijkwel P.P.\",\"Young C.A.\",\"Scott B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"30452111\"},{\"database\":\"DOI\",\"id\":\"10.1111/1462-2920.14483\"}],\"citationType\":\"journal article\",\"firstPage\":\"928\",\"id\":\"30452111\",\"journal\":\"Environ. Microbiol.\",\"lastPage\":\"939\",\"publicationDate\":\"2019\",\"title\":\"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\",\"volume\":\"21\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"ARSEF 297\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10",
  "source_sha256": "ddc350505f9daf759d0d04d56b92ba49afb5a19348f35aee2a744b896e240a4d",
  "retrieved_utc": "2026-11-02T04:25:19.015576+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   PPZF_METMF              Reviewed;         340 AA.\nAC   A0A455ZLR3;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-JUN-2019, sequence version 1.\nDT   09-APR-2025, entry version 10.\nDE   RecName: Full=Sulfotransferase ppzF {ECO:0000303|PubMed:30452111};\nDE            EC=2.8.2.- {ECO:0000305|PubMed:30452111};\nDE   AltName: Full=Pyrrolopyrazine biosynthesis cluster protein F {ECO:0000303|PubMed:30452111};\nGN   Name=ppzF {ECO:0000303|PubMed:30452111};\nOS   Metarhizium majus (strain ARSEF 297).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Clavicipitaceae; Metarhizium;\nOC   Metarhizium majus.\nOX   NCBI_TaxID=1276143;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10",
  "source_sha256": "ddc350505f9daf759d0d04d56b92ba49afb5a19348f35aee2a744b896e240a4d",
  "retrieved_utc": "2026-11-02T04:25:19.015576+00:00",
  "source_locator": "lines 15-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=ARSEF 297;\nRX   PubMed=30452111; DOI=10.1111/1462-2920.14483;\nRA   Berry D., Mace W., Rehner S.A., Grage K., Dijkwel P.P., Young C.A.,\nRA   Scott B.;\nRT   \"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene\nRT   clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\";\nRL   Environ. Microbiol. 21:928-939(2019).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZLR3?format=txt&versions=10",
  "source_sha256": "ddc350505f9daf759d0d04d56b92ba49afb5a19348f35aee2a744b896e240a4d",
  "retrieved_utc": "2026-11-02T04:25:19.015576+00:00",
  "source_locator": "lines 50-55",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000305|PubMed:30452111}.\nCC   ---------------------------------------------------------------------------\nCC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\nCC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\nCC   ---------------------------------------------------------------------------\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 147. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
